This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Alleyn Plowright: Innovator in Cancer Treatment
Introduction
Alleyn Plowright is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Plowright holds a patent for quinazoline derivatives and their use in the treatment of cancer. This invention concerns quinazoline derivatives of a specific formula, which act as erbB tyrosine kinase inhibitors, particularly targeting EGFR tyrosine kinase. The patent also includes processes for the preparation of these compounds, pharmaceutical compositions containing them, and their therapeutic applications in treating erbB tyrosine kinase mediated diseases such as cancer.
Career Highlights
Alleyn Plowright is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work focuses on developing innovative treatments that can significantly impact patient outcomes in oncology.
Collaborations
Plowright has collaborated with Laurent Francois Andre Hennequin, contributing to advancements in the field of cancer research and treatment.
Conclusion
Alleyn Plowright's work exemplifies the vital role of innovation in the fight against cancer. His contributions through patents and collaborations continue to pave the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile